#Disposable Syringes Market share

[mordorintelligencemarketresearch]

The Disposable Syringes Industry: A Critical Component of Modern Healthcare

The disposable syringes industry has become a cornerstone of modern healthcare, offering a safe, sterile, and convenient solution for administering medications and collecting biological samples. With the increasing demand for infection control, vaccination programs, and advancements in medical treatments, disposable syringes have emerged as an essential tool for healthcare providers worldwide. Their single-use nature reduces the risk of cross-contamination and ensures patient safety, making them indispensable in hospitals, clinics, and home healthcare settings. 

The disposable syringes market is estimated to be valued at USD 15.77 billion in 2024 and is expected to expand to USD 24.86 billion by 2029, with a compound annual growth rate (CAGR) of 9.53% during the forecast period of 2024 to 2029.. 

Importance of Disposable Syringes in Healthcare 

Disposable syringes are pre-sterilized, single-use medical devices designed to deliver medications, vaccines, or fluids into the body or withdraw blood and other fluids for diagnostic purposes. They have largely replaced reusable syringes due to their safety and convenience. Key advantages include: 

Infection Prevention: Single-use syringes eliminate the risk of transmitting bloodborne infections such as HIV, hepatitis B, and hepatitis C. 

Ease of Use: Pre-sterilized and ready to use, disposable syringes save time and effort in healthcare settings. 

Cost-Effectiveness: While reusable syringes require cleaning, sterilization, and maintenance, disposable syringes reduce these associated costs. 

Wide Applicability: Used in a variety of settings, including hospitals, clinics, research laboratories, and for at-home care. 

The industry has witnessed tremendous growth as healthcare providers and regulatory agencies emphasize safety and hygiene, especially in the wake of global health crises like the COVID-19 pandemic. 

Key Drivers of Growth in the Disposable Syringes Industry 

1. Rising Demand for Vaccination Programs 

Mass immunization campaigns against diseases such as COVID-19, influenza, measles, and polio have significantly boosted the demand for disposable syringes. Governments and international organizations have prioritized the use of safe injection practices, driving the widespread adoption of disposable syringes. 

2. Increasing Prevalence of Chronic Diseases 

Chronic conditions such as diabetes, cardiovascular diseases, and autoimmune disorders often require regular medication administration through injections. The growing number of patients with these conditions has led to higher demand for disposable syringes for both clinical and at-home use. 

3. Enhanced Focus on Infection Control 

The global emphasis on infection prevention, particularly in healthcare settings, has underscored the importance of disposable syringes. Regulatory bodies and healthcare organizations advocate for their use to reduce the risk of healthcare-associated infections (HAIs). 

4. Expansion of Point-of-Care and Home Healthcare 

The rise of point-of-care diagnostics and home-based healthcare services has further propelled the demand for disposable syringes. Patients with chronic illnesses or those requiring long-term care often use disposable syringes for self-administration of medications, ensuring convenience and safety. 

5. Technological Advancements in Syringe Design 

Innovations in syringe design, such as auto-disable (AD) syringes and safety syringes, have added value to the industry by enhancing user safety and reducing the risk of needle-stick injuries. These advancements align with global healthcare trends prioritizing safety and sustainability. 

Challenges Facing the Disposable Syringes Industry 

1. Environmental Impact 

The single-use nature of disposable syringes contributes to medical waste, posing environmental challenges. Improper disposal can lead to contamination and harm to ecosystems, prompting the need for sustainable waste management solutions. 

2. Fluctuating Raw Material Costs 

Disposable syringes are primarily made of plastic, and fluctuations in the prices of raw materials such as polypropylene can impact production costs. Manufacturers often face challenges in maintaining affordability while ensuring quality. 

3. Regulatory Compliance 

The production and distribution of disposable syringes must adhere to strict regulatory standards for safety, quality, and sterilization. Navigating these regulations can be time-consuming and costly, particularly for smaller manufacturers. 

4. Supply Chain Disruptions 

Global supply chain disruptions, such as those experienced during the COVID-19 pandemic, can affect the availability of raw materials and the timely delivery of syringes. This poses a challenge for meeting surges in demand during health crises. 

5. Competition from Alternative Delivery Methods 

While disposable syringes remain a dominant choice, alternative drug delivery methods, such as transdermal patches, oral medications, and needle-free injectors, are gaining traction. These innovations present competition and may influence the market dynamics over time. 

Innovations and Emerging Trends in the Disposable Syringes Industry 

1. Adoption of Safety Syringes 

Safety syringes, equipped with mechanisms to prevent needle-stick injuries, are becoming increasingly popular. These include retractable syringes and those with protective shields to enhance user and patient safety. 

2. Growth of Auto-Disable Syringes 

Auto-disable syringes, designed for single-use with a mechanism that disables the syringe after injection, are in high demand. These are particularly favored in vaccination programs in low- and middle-income countries to prevent reuse and ensure safe disposal. 

3. Eco-Friendly Solutions 

To address environmental concerns, manufacturers are exploring biodegradable materials and recycling programs for disposable syringes. Innovations in sustainable production processes aim to reduce the carbon footprint of syringe manufacturing. 

4. Integration with Smart Technology 

Smart syringes equipped with digital tracking and monitoring capabilities are emerging in the healthcare landscape. These devices help ensure accurate dosage and provide data for patient records, improving treatment outcomes. 

5. Regional Manufacturing Hubs 

To address supply chain challenges, companies are establishing regional manufacturing hubs to meet local demand efficiently. This trend is particularly evident in emerging markets, where healthcare infrastructure is expanding rapidly. 

The Role of Disposable Syringes During Global Health Crises 

The COVID-19 pandemic highlighted the critical importance of disposable syringes in combating global health emergencies. Mass vaccination efforts required billions of syringes, prompting rapid production scale-ups and international collaborations. The pandemic also underscored the need for resilient supply chains and sustainable practices in the industry. 

Conclusion 

The disposable syringes industry is a vital component of the global healthcare system, enabling safe and efficient administration of medications and vaccines. Driven by rising healthcare needs, advancements in technology, and increased focus on infection control, the industry continues to expand and innovate. 

While challenges such as environmental impact and regulatory compliance remain, the adoption of eco-friendly solutions, safety-enhancing designs, and smart technologies are reshaping the industry’s future. Disposable syringes will remain indispensable in healthcare, playing a critical role in improving patient outcomes, supporting public health initiatives, and addressing global health challenges. As the world navigates evolving healthcare demands, the disposable syringes industry is poised to make significant contributions to the well-being of communities worldwide.    For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence: https://www.mordorintelligence.com/industry-reports/disposable-syringes-market 

[marketwire]

Disposable Syringes Market - Forecast(2024 - 2030)

Disposable Syringes Market Overview:

Disposable Syringes Market size is estimated to reach $24 billion by 2030, growing at a CAGR of 6.7% during the forecast period 2023-2030. The rising demand for injectable medications and increasing adoption of telemedicine are propelling the Disposable Syringes Market growth.

Additionally, the education and training programs for healthcare providers and end-users on the proper use, handling and disposal are creating substantial growth opportunities for the Disposable Syringes Market. As per U.S. Bureau of Labor Statistics, health education specialists and community health workers are expected to grow at a significant rate of 12% by 2031, exceeding the average growth rate for all occupations. This reflects the increasing demand for these professionals and underscores their crucial role in advancing public health and wellness. These factors positively influence the Disposable Syringes industry outlook during the forecast period.

Market Snapshot:  Disposable Syringes Market - Report Coverage:

The “Disposable Syringes Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Disposable Syringes Market.

Attribute

Segment

By Type

Safety Syringes

Conventional Syringes

Prefilled Syringes

Insulin Syringes

Others

By Syringe Size

Below 5ml

5-10ml

Above 10ml

By Application  

Therapeutic Injections

Immunization Injections

Blood Sample Collection

Others

By End-User

Diagnostics Laboratories

Hospital

Pharmaceutical Industry

Blood Banks

Veterinary

Others

By Geography

North America (U.S., Canada and Mexico)

Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific)

South America (Brazil, Argentina, Chile, Colombia and Rest of South America)

Rest of the World (Middle East and Africa).

 

COVID-19 / Ukraine Crisis - Impact Analysis:

●        The COVID-19 pandemic has created a heightened demand for disposable syringes due to the urgent need for vaccination campaigns worldwide. Vaccination programs require massive quantities of syringes for administering vaccines, which has resulted in increased production and sales of disposable syringes.

●        The Ukraine crisis has disrupted the supply chain of disposable syringes, including procurement of raw materials, manufacturing and distribution. This can result in challenges in the availability and accessibility of disposable syringes, potentially leading to supply shortages and production delays.

Key Takeaways:

●        Fastest Growth of Rest of the World : Geographically, in the global Disposable Syringes Market share, Rest of the World is analyzed to grow with the highest CAGR of 7.3% during the forecast period 2023-2030. The growth is attributed to the rising healthcare expenditure and infrastructure development in emerging economies. Moreover, the increasing prevalence of chronic diseases and the growing demand for injectable medications are also fueling the market. In November 2021, Revital Healthcare (EPZ) Limited, a Kenyan medical supply manufacturer, announced that it had received nearly $4 million from the Bill & Melinda Gates Foundation to expand the production of auto-disable vaccine syringes. This funding allowed Revital to increase syringe production volume from approximately 72 million.

●        Therapeutic Injections is Leading the Market : According to the Therapeutic Injections Market forecast, the Therapeutic Injections held the largest market valuation of $5.9 billion in 2022 owing to the increasing prevalence of chronic diseases, rising demand for injectable medications and advancements in therapeutic treatments. Therapeutic injections are commonly used for administering medications for conditions such as diabetes, cancer, autoimmune diseases and others.

●        Prefilled Syringes to Register the Fastest Growth : In the Disposable Syringes Market analysis, the Prefilled Syringes segment is estimated to grow with the highest CAGR of 7.2% during the forecast period. The increasing demand for efficient and convenient drug delivery systems drives the adoption of prefilled syringes. These syringes come pre-loaded with a precise dosage of medication, eliminating the need for manual filling and reducing the risk of dosing errors. In May 2022, Terumo Corporation introduced a pre-fillable polymer syringe designed for low-dose applications. This innovative product provides a safe, user-friendly, and efficient treatment solution, catering to the needs of healthcare professionals and patients alike.

●         Adoption of  Injectable Medication : The demand for injectable medications is on the rise due to the increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases and the growing aging population as well as advancements in therapeutic treatments. Injectable medications are preferred for their fast and effective delivery, precise dosing and ease of administration. In 2022, as per Drug Development & Delivery article, the growth of the injectable drug delivery is projected reach of $83.38 billion by 2030 which demonstrates the rising demand for efficient and convenient administration of medication through injectable routes.

●        Increasing Adoption of Telemedicine : Telemedicine enables patients to consult with healthcare professionals remotely, facilitating remote diagnosis, monitoring and prescription of medications. Disposable syringes play a crucial role in facilitating safe and convenient self-administration of injectable medications for chronic diseases like diabetes and autoimmune disorders. Syringes with their convenience, ease of use and disposable nature have become an essential tool in the telemedicine ecosystem which is driving the demand and growth of the market. In 2022, according to the NCBI report, over 57% of individuals aged 0-17 showed a high inclination towards using telehealth services and indicating a strong willingness among younger individuals to adopt telemedicine.

●        High Cost and Affordability Hamper the Market Growth : Expensive production processes, raw material costs and pricing limit accessibility, especially in resource-constrained settings and pose challenges for patients, healthcare providers and healthcare systems in procuring and using disposable syringes.This factor impedes the Disposable Syringes market growth.

Disposable Syringes Market Share (%) By Region, 2022

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Disposable Syringes Market. The top 10 companies in this industry are listed below:

Baxter International Inc. (BD® 60 mL Luer syringes)

Medtronic plc (i-Port AdvanceTM)

Fresenius Kabi AG (Amicus® Extracorporeal)

Terumo Corporation (PLAJEX™ COP,  Safe'n'Sound®)

B. Braun SE (Original Perfusor® Syringes, Omnifix® Lock)

Becton, Dickinson and Company. (Ultra-Fine™, Safety-Glide™)

Novo Nordisk A/S (FlexPen®, NovoPen® 5)

Retractable Technologies, Inc. (VanishPoint®, Patient Safe®)

Henke-Sass, Wolf GmbH (HSW HENKE-JECT®– two-part, HSW HENKE-JECT® Insulin)

Nipro Corporation (Dual chamber bags PLW®, Pre-filled syringes [PFS®])

Scope of the Report: 

Report Metric

Details

Base Year Considered

2022

Forecast Period

2023–2030

CAGR

6.7%

Market Size in 2030

$24 billion

Segments Covered

Type, Syringes Size, Application, End-User and Region

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players

            Baxter International Inc.

            Medtronic plc

            Fresenius Kabi AG

            Terumo Corporation

            B. Braun SE

            Becton, Dickinson and Company.

            Novo Nordisk A/S

            Retractable Technologies, Inc.

            Henke-Sass, Wolf GmbH

            Nipro Corporation

For more Lifesciences and Healthcare Market reports, please click here

[global-research-report]

From Safety to Sustainability: Trends in the Syringes Market

The global syringes market size is expected to reach USD 25.7 billion by 2026, expanding at a CAGR of 8.5%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, increasing number of surgical procedures, growing adoption of injectable drugs, favorable initiatives taken by government organizations, and increasing geriatric population across the globe are the key driving factors for the market.

Chronic inflammatory diseases such as Crohn’s disease and rheumatoid arthritis can be treated through self-administration of drugs. For instance, as per the U.S. Department of Health and Human Services, in 2015, approximately 3.0 million people were diagnosed with either Crohn’s disease or ulcerative colitis, which was a huge increase from 2.0 million people in 1999. In addition, as per the Arthritis Foundation, arthritis is the major cause of disability in the U.S. It also reported that in 2019, approximately 54.0 million adults have been diagnosed with arthritis by the doctors, which is anticipated to increase to more than 78.0 million by 2040.

North America accounted for highest syringes market share in 2018 attributed to advent of technologically advanced medical devices and growing prevalence of chronic diseases. In addition, presence of major players in the region contributed to regional growth. Prominent players operating the region include Thomas Scientific; Smiths Medical; BD; Cardinal Health; McKesson Medical-Surgical Inc.; and B. Braun Melsungen AG.

Moreover, key companies such as BD and Smiths Medical, are launching products specifically for chronic disease treatment to strengthen their foothold in the industry. For instance, BD offers Hypak SCF PRTC glass pre-fillable syringe, used in the treatment of chronic diseases. Such factors are anticipated to boost the industry growth over the forecast period.

Syringes Market Report Highlights

By product, the general segment held the largest market share in 2018 as they are commonly used for various conditions such as tetanus and vaccination

Disposable needles held the largest market share in 2018 and are anticipated to witness the fastest growth over the forecast period as they reduce the risk of contamination, significantly

The hospital segment held the largest market share owing to the increasing number of chronic disease patients and rising number of surgeries

The Asia Pacific market is expected to witness the fastest growth over the forecast period owing to the rising demand for vaccines and immunization in this region

Prominent players in the syringes market are BD; Smiths Medical; B. Braun Melsungen AG; NIPRO Medical Corporation; Hindustan Syringes and Medical Devices Ltd.; Gerresheimer AG; SCHOTT AG; CODAN Medizinische Geräte GmbH and Co KG; McKesson Medical-Surgical Inc.; and Cardinal Health. The key players are adopting various strategies such as product launch, partnership, and merger and acquisition to strengthen their foothold in the market

Syringes Market Segmentation

Grand View Research has segmented the global syringes market on the basis of product, usage, end use, and region:

Syringes Product Outlook (Revenue, USD Million, 2015 - 2026)

General Syringes

Specialized Syringes

Insulin

Tuberculin (TB)

Allergy

Smart Syringes

Auto-Disable

Active Safety

Passive Safety

Syringes Usage Outlook (Revenue, USD Million, 2015 - 2026)

Reusable Syringes

Disposable Syringes

Empty

Prefilled

Syringes End-use Outlook (Revenue, USD Million, 2015 - 2026)

Hospitals

Blood Collection Centers

Diabetic Care Centers

Others

Syringes Regional Outlook (Revenue, USD Million, 2015 - 2026)

North America

US

Canada

Europe

UK

Germany

Asia Pacific

Japan

China

Latin America

Brazil

Mexico

MEA

South Africa

Saudi Arabia

Order a free sample PDF of the Syringes Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Medical Component Manufacturing Market Key Players, Revenue And Growth Rate

The global medical component manufacturing market size is expected to reach USD 15.93 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 4.4% from 2021 to 2030. The rising demand for 3D printed parts in the medical industry is projected to contribute to market growth.

Penetration is the adoption of medical component manufacturing in various applications in the market. The penetration of medical component manufacturing is likely to be the highest in the 3D printing segment. The benefits of 3D printing such as improved productivity, cost-effectiveness, personalization, and customization of medical products, applications in complex operations, and rapid medical prototyping are projected to benefit the growth of the 3D printing market.

The plastic injection molding process segment accounted for the largest revenue share of over 65.0% in 2020. The segment is projected to grow due to the development of efficient products using better-engineered resins. Moreover, the process can help component manufacturers produce cost-effective products in various sizes and shapes. Some of the low-cost products include disposable gloves, syringes, plastic instruments, and different one-time products for healthcare facilities.

The rising geriatric population is projected to remain an indirect contributor to market growth. There has been a change in the pattern of the aging population across the globe in the recent past owing to the decreasing levels of fertility and rising life expectancy. This has led to a longer lifespan of people, wherein the share of old people or geriatric population is growing at a rapid pace. As per the United Nations, there are over 727 million people globally who are aged 65 or above as of 2020.

Gather more insights about the market drivers, restrains and growth of the Medical Component Manufacturing Market

Medical Component Manufacturing Market Report Highlights

• The 3D printing process segment is anticipated to register the fastest CAGR of 20.8% from 2021 to 2030. Suitability to produce complex and customized products, along with cost efficiency in low volume production, is projected to drive the segment over the forecast period

• The plastic injection molding process segment held the largest revenue share of over 65.0% in 2020. Advantages such as durability, strength, ease of handling, and improved sterilization make the process comply with stringent regulations set by different government bodies

• North America accounted for the largest revenue share of over 40.0% in 2020. The Increasing geriatric population, along with a rise in lifestyle diseases, is projected to benefit the growth of the medical device industry in the region, thus benefiting the demand for various medical components

• Leading companies in the industry are focused on the development of advanced processes such as 3D printing and are likely to increase their R&D expenditure over the coming years. The merger & acquisition activities are anticipated to rise over the coming years as companies are focused on improving their market share

Medical Component Manufacturing Market Segmentation

Grand View Research has segmented the global medical component manufacturing market on the basis of process and region:

Medical Component Manufacturing Process Outlook (Revenue, USD Billion, 2017 - 2030)

• Forging

• Metal Injection Molding

• 3D Printing

• Ceramic Injection Molding

• Investment Casting

• Plastic Injection Molding

Medical Component Manufacturing Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America

o U.S.

• Europe

o Germany

o France

o U.K.

o Spain

• Asia Pacific

o China

o India

o Japan

Order a free sample PDF of the Medical Component Manufacturing Market Intelligence Study, published by Grand View Research.

[kristinahertzz]

Insulin Pen Market

Insulin Pen Market Size, Share, Trends: Novo Nordisk A/S Lead

Smart insulin pens revolutionizing diabetes management with connected health solutions

Market Overview:

The global Insulin Pen Market is projected to grow at a CAGR of 8.2% from 2024 to 2031. The market value is expected to increase from USD XX billion in 2024 to USD YY billion by 2031. North America currently dominates the market, followed closely by Europe. Key metrics include rising diabetes prevalence, increasing adoption of insulin pens over traditional vials and syringes, and technological advancements in insulin delivery devices. The market is experiencing steady growth due to the rising global diabetic population and the increasing preference for convenient and accurate insulin delivery methods.

DOWNLOAD FREE SAMPLE

Market Trends:

The insulin pen market is rapidly shifting towards smart, connected devices that provide better patient care and data management. These innovative pens employ Bluetooth technology to connect to smartphone apps, allowing users to check insulin dosages, create reminders, and share data with healthcare specialists. This trend is being driven by a growing desire for personalised diabetes care options, as well as an increase in the use of digital health technologies. Smart insulin pens provide significant information about patients' insulin use patterns, allowing healthcare practitioners to make more informed treatment decisions.

Market Segmentation:

Disposable insulin pens dominate the market due to their convenience and reduced risk of contamination. Disposable insulin pens have emerged as the market's main category, accounting for a sizable portion of total sales. These pens are pre-filled with insulin and designed for single use, providing users with a convenient and sanitary way to administer insulin.

Recent advances in disposable insulin pen technology have strengthened their commercial position. For example, prominent pharmaceutical companies have produced disposable pens with better dose precision and ergonomic designs, which increase user experience and patient compliance.

Market Key Players:

Novo Nordisk A/S

Eli Lilly and Company

Sanofi S.A.

Biocon Ltd.

Ypsomed AG

Becton, Dickinson and Company

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[willyskristina]

Disposable Syringes Market

Disposable Syringes Market Size, Share, Trends: Becton, Dickinson and Company (BD) Leads

Shift Towards Safety-Engineered Syringes to Prevent Needlestick Injuries and Reduce Healthcare-Associated Infections

Market Overview:

The Disposable Syringes Market is projected to grow significantly, driven by increasing healthcare expenditure, the rising prevalence of chronic diseases, and growing awareness about infection control. Asia-Pacific stands out as the fastest-growing region, accounting for a substantial share of the global market. This growth is propelled by the region's vast population base, rising healthcare spending, and increased awareness of safe injection techniques.

The market is experiencing a considerable shift towards safety-engineered syringes, with built-in safety features to prevent needlestick injuries and limit the danger of bloodborne pathogen transmission. This trend is further fueled by severe rules in many countries that require the use of safety equipment in healthcare settings. 

DOWNLOAD FREE SAMPLE

Market Trends:

The disposable syringe market is witnessing a significant shift towards safety-engineered syringes. These modern gadgets include built-in safety features to avoid needlestick injuries and limit the danger of bloodborne pathogen transmission. According to research analysis, safety syringes can reduce needlestick injuries by up to 80% compared to traditional syringes. This tendency is further driven by stringent regulations in many countries that require the use of safety devices in healthcare settings.

Market Segmentation:

Safety syringes dominate the disposable syringes market, accounting for a significant share of the market. This dominance is linked to a growing emphasis on healthcare worker safety and strict regulations requiring the use of safety devices in medical environments. Safety syringes, which include features such as retractable needles and protective covers, have demonstrated exceptional success in preventing needlestick injuries. A recent study found that implementing safety syringes in a large hospital system reduced percutaneous injuries among healthcare workers by 74% over a five-year period.

The long-term cost-effectiveness of safety syringes drives the segment's expansion further. While initially more expensive than traditional syringes, safety devices greatly lower the expenses of needlestick injuries, such as testing, treatment, and lost productivity. Technological breakthroughs in safety syringe design have increased user acceptance and patient satisfaction, leading to higher compliance rates and enhanced safety in healthcare settings.

Market Key Players:

Prominent players in the disposable syringes market include Becton, Dickinson and Company (BD), Terumo Corporation, B. Braun Melsungen AG, Smiths Medical, Nipro Corporation, Hindustan Syringes & Medical Devices Ltd., Cardinal Health, Retractable Technologies, Inc., Gerresheimer AG, and Schott AG. These companies are leading the market with their innovative approaches, extensive product portfolios, and robust distribution networks, continuously setting industry standards and driving market growth.

Contact Us:

Name: Hari Krishna

Email us: hari.krishna@aurorawaveintellects.com

Website: https://aurorawaveintellects.com/

[credenceresearchdotblog]

The Disposable Hypodermic Syringes Market is projected to grow significantly, with its market size estimated to increase from USD 4,395 million in 2024 to USD 9,037.53 million by 2032, reflecting a compound annual growth rate (CAGR) of 9.43% during the forecast period. The global disposable hypodermic syringes market is witnessing robust growth, fueled by advancements in healthcare, rising prevalence of chronic diseases, and increasing awareness of safety protocols in medical practices. Disposable syringes, primarily used for administering medications and vaccinations, have become indispensable in modern healthcare due to their convenience, affordability, and ability to reduce the risk of cross-contamination. This article explores the dynamics, drivers, challenges, and future prospects of this essential medical device market.

Browse the full report at https://www.credenceresearch.com/report/disposable-hypodermic-syringes-market

Market Overview

Disposable hypodermic syringes are single-use medical devices designed for various healthcare applications, such as drug administration, blood collection, and therapeutic injections. Unlike reusable syringes, they are designed to be discarded after a single use, ensuring hygienic and safe practices.

Globally, the market is experiencing significant growth, with projections indicating a compound annual growth rate (CAGR) of around 5-7% from 2023 to 2030. Key factors contributing to this growth include the rising demand for vaccinations, especially following the COVID-19 pandemic, and increased government initiatives promoting safe injection practices.

Key Market Drivers

Increased Demand for Vaccination Programs Vaccination programs, particularly in response to global health crises like COVID-19, have driven the mass production and use of disposable syringes. The rollout of immunization programs for diseases such as measles, influenza, and polio has further fueled market demand.

Rising Prevalence of Chronic Diseases Chronic conditions such as diabetes, cardiovascular diseases, and cancer require frequent administration of injectable medications. The rising incidence of these diseases globally has boosted the demand for disposable syringes.

Enhanced Safety and Infection Control Measures The use of disposable syringes eliminates the risk of needle-sharing and cross-contamination. Governments and health organizations, such as the World Health Organization (WHO), advocate for the use of auto-disable syringes, which render them unusable after a single use.

Technological Advancements Innovations such as syringes with built-in safety features (e.g., retractable needles) and eco-friendly materials are enhancing product appeal and compliance with safety standards.

Challenges

Environmental Concerns The disposal of single-use plastic syringes poses a significant environmental challenge. Regulatory agencies and manufacturers are exploring biodegradable and recyclable materials to address this issue.

Price Sensitivity in Developing Markets While safety syringes are gaining popularity, their higher costs remain a barrier in low- and middle-income countries.

Counterfeit Products The market faces challenges from counterfeit syringes, which can compromise patient safety and tarnish brand reputations.

Future Prospects

The disposable hypodermic syringes market is poised for sustained growth, driven by the following:

Regulatory Push: Governments mandating the use of safety syringes and banning reusable options in healthcare facilities.

R&D Investments: Manufacturers investing in innovative products that balance safety, cost-effectiveness, and environmental sustainability.

Global Health Initiatives: Programs by organizations like UNICEF and Gavi to vaccinate underserved populations.

Key Player Analysis:

Becton, Dickinson and Company (BD)

Terumo Corporation

Nipro Corporation

Braun Melsungen AG

Smiths Medical

Cardinal Health

Hindustan Syringes & Medical Devices Ltd. (HMD)

Gerresheimer AG

Retractable Technologies, Inc.

Teleflex Incorporated

Segmentations:

By Material Type:

Polymer Syringes

Cyclic Olefin Polymers (COP)

Cyclic Olefin Copolymers (COC)

Polypropylene and Other Polymers

Glass Syringes

By Sales Channel:

Manufacturers

Distributors

Retailers

By End User:

Hospital

Diabetic Care Centers

Blood Collection Centers

Veterinary Care Centers

Clinics

By Region:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/disposable-hypodermic-syringes-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

[latestmarketresearchnews]

Medical Plastics Market Size, Share, Growth Analysis And Forecast Report 2030

The global medical plastics market was valued at approximately USD 52.9 billion in 2023 and is projected to experience a steady growth rate, with a compound annual growth rate (CAGR) of 7.4% expected between 2024 and 2030. The significant growth in this sector can be attributed to the advancements in the development of plastics and plastic composites used in medical applications, particularly in the production of essential components such as catheters, handles for surgical instruments, and syringes. A rising demand for sophisticated medical devices, especially for in-house use, is expected to drive the need for medical device packaging. Materials like polyethylene, polypropylene, and polycarbonate are becoming increasingly important in the manufacturing of medical devices. Additionally, the expansion of home healthcare owing to its cost-effectiveness compared to hospital-based or intensive care has fueled a greater need for various medical devices.

Demographic trends in the U.S. further support this market growth. According to the latest U.S. census, 16.8% of the U.S. population is aged 65 years and older, with the elderly population expected to reach 74 million by 2030. Notably, individuals over the age of 85 typically require the most intensive care, and this age group is expanding rapidly. In response to this growing need for elderly care, in March 2021, U.S. President Joe Biden proposed a significant investment of USD 400 billion over an eight-year period into Medicaid to support at-home care services for elderly and disabled individuals. This plan also aimed to increase the wages of caregivers. The rising costs and shrinking profit margins have put considerable pressure on healthcare providers and health insurance plans in the U.S., leading the government to implement crucial changes in healthcare funding and insurance coverage, including reforms introduced through the Affordable Care Act (ACA) and Medicaid.

Gather more insights about the market drivers, restrains and growth of the Medical Plastics Market

Product Segmentation Insights:

The Polyphenylsulfone (PPSU) resin segment led the medical plastics market in 2023, accounting for over 51% of the total revenue. This dominance is largely due to the material's excellent heat and chemical resistance, which makes it particularly suited for producing durable surgical tools and medical devices. PPSU's high strength and resilience make it a preferred material in the production of surgical robots and components used in biopharmaceutical processing. Additionally, its high flexural strength and impact resistance are beneficial for producing both single-use and multi-use surgical instruments, especially those that require repeated sterilization via steam.

Polyethylene (PE) is another important material in the medical plastics sector, valued for its resistance to bacteria and cleaning chemicals, making it ideal for use in medical equipment, devices, and other healthcare supplies. Its key characteristics such as impact resistance, chemical stability, flexibility, and minimal moisture absorption make PE suitable for use in medical-grade devices. Moreover, because it is a porous synthetic polymer that does not degrade within the human body, PE is used in various medical applications, including plastic surgery implants, tubing, and bottles.

Polypropylene (PP) is extensively used in the production of medical equipment and protective packaging, thanks to its toughness and durability. The strong chemical bonds of PP make it suitable for producing medical components like disposable syringes, connectors, finger-joint prostheses, non-absorbable sutures, reusable plastic containers, and laboratory items such as beakers and test tubes. Furthermore, PP is particularly beneficial in specialized medical procedures, such as hernia repairs and pelvic organ prolapse surgeries, where it is used in transvaginal mesh implants.

Order a free sample PDF of the Medical Plastics Market Intelligence Study, published by Grand View Research.

[coolkailas]

Future of Medical Tubing Industry

The report "Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems, Specialty Applications), Structure, and Region - Global Forecast to 2028", is projected to reach USD 15.7 billion by 2028, at a CAGR of 8.2% from USD 10.6 billion in 2023.

Download PDF Brochure at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162082103

Browse 218 market data Tables and 40 Figures spread through 249 Pages and in-depth TOC on "Medical Tubing Market by Material (Plastics, Rubbers, Specialty Polymers), Application (Bulk Disposable Tubing, Catheters & Cannulas, Drug Delivery Systems, Specialty Applications), Structure, and Region - Global Forecast to 2028" View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-tubing-market-162082103.html

The Medical tubing market is driven by increasing demand for minimally invasive medical procedures, growing adoption of advanced medical technologies, development of novel technology, increasing demand for medical tubing in healthcare industry, and stringent regulations for medical devices.

“Rubber is projected to be the largest material of medical tubing, in terms of value, during the forecast period.”

Rubber medical tubing is made from different materials such as silicone, polyurethane, latex, thermoplastic elastomer, ethylene propylene diene monomer, and thermoplastic polyurethane. These tubes are flexible, durable, and abrasion-resistant, making it suitable for various medical applications. It is used for various applications such as blood transfusion, IV transfusion tubing, respiratory tubing, urological products, syringes, needles, surgical instruments, and others.

“Catheters & cannulas is projected to be the largest application of the medical tubing, in terms of value.”

Catheters & cannulas are medical tubes used for healthcare applications such as medication, drainages of fluids, and blood pressure measurement. The catheters & cannulas market is driven by increasing cardiovascular diseases and the growing demand for minimally invasive surgeries. Consumers are opting for minimally invasive surgeries, as the procedure reduces the time of stay in hospitals during treatment, which lowers the overall costs a patient will incur during the treatment.

Request For FREE Sample of Report at https://www.marketsandmarkets.com/requestsampleNew.asp?id=162082103

“North America captures the largest share in the medical tubing market during the forecast period, in terms of value.”

The North America region is a significant market for medical tubing, driven by high awareness of medical tubing for applications such as bulk disposable tubing, catheters & cannulas, drug delivery devices, special applications in the healthcare sector, and large-scale production in the region, technological advancements, aging population, and stringent regulatory standards.

Mergers, new product launches and expansions are the major growth strategies adopted by the key players in the market. The key global players in the medical tubing market include Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), Lubrizol Corporation (US), TE Connectivity (Switzerland), Nordson Corporation (US), Elkem ASA (Norway), Raumedic AG (Germany), Teknor Apex (US), and Spectrum Plastics Group (US).

Don’t miss out on business opportunities in Medical Tubing Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

[industryinsightsandanalysis]

MENA Syringes & Cannula Market: Current Analysis and Forecast (2024-2032)

According to the UnivDatos Market Insights analysis, increasing healthcare expenditure, rising prevalence of chronic diseases, growing geriatric population, government initiatives, expansion of healthcare facilities, advancements in medical procedures, and emerging as a medical tourism destination for advanced healthcare services will drive the scenario of the Syringes & Cannula market. As per their “MENA Syringes & Cannula Market” report, the market was valued at USD 1,505.79 million in 2023, growing at a CAGR of 7.29% during the forecast period from 2024 – 2032.

The healthcare industry in the MENA region is evolving rapidly due to occurrences within the region and the active actions of governments. Critical to this process is the utilization and need for Medical Devices like syringes and cannulas, which are essential in most procedures, from simple injections to complicated surgeries.

Enhanced Healthcare Expenditure and Government Initiatives

Even though most MENA countries are classified as developing, the governments are passionately trying to increase health spending. This increase in the financial share is intended to increase the number of healthcare clinics and ensure that these facilities are well-equipped with relevant products like syringes and cannulas. For instance, Vision 2030 of Saudi Arabia aims to modify the kingdom’s healthcare system, which entails upgrading the technical health infrastructure and providing adequate healthcare facilities.

Similarly, the UAE’s Ministry of Health and Prevention has stepped up efforts to improve the quality of healthcare services. Lastly, the Ministry has set regulations to license high-end products, directly affecting the syringes and cannula market. These initiatives are important as some of them act as guidelines that aim at bringing some level of uniformity in the quality of health services delivered by health practitioners and also in commercialized health services, an aspect that increases the probability of health hazards being minimized due to the safety and efficiency of the medical procedures offered.

Current Trends and Developments in the Market

Recent news includes the following events in the MENA region that are influencing the syringe and cannula market. For instance, a new regulation recently imposed in Egypt requires all syringes to be produced with safety precautions, not allowing reuse, to reduce the rate of infection. This regulation alters the existing situation regarding syringes in Egypt and becomes guidance for other countries as well.

Another new development is that Jordan has recently secured a joint venture with a multinational pharmaceutical company to set up a new industrial equipment factory for medical utensils such as syringes and cannula. Medical and health local economy in Jordan but also an attempt to gradually provide medical products in the Middle East relying on local production.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=61467

Regional Collaboration and Innovation:

The countries of the MENA region are slowly realizing the need to engage in regional cooperation in this particular sphere. Among them, the Gulf Cooperation Council (GCC) has led other countries as members to undertake healthcare projects in cooperation. These include common electronic health records and records exchange networks as well as common purchasing contracts for supplies, where aspects such as costs and quality of products like syringes and cannulas are improved.

Technological advancement is also a major factor in the regional market. For instance, researchers in Qatar are in the process of designing biodegradable cannula in a bid to deal with the issue of medical waste and safely dispose of hazardous products for the benefit of patients. This innovation not only serves as a threat to the existing products in the market but also avails the MENA region as a global significant of sustainable healthcare practices.

Difficulties and Future Prospectives:

However, some issues can act as a barrier to the delivery of health care in this region, including political instabilities in some parts and economic imbalances that might affect the uniform distribution of health care supplies. Furthermore, with the ongoing pandemic worldwide, the use of syringes and cannulas in healthcare facilities and other applications has increased, thus exerting more pressure on supply chains.

To deal with these challenges, healthcare infrastructure, strong government policies, regional cooperation, etc., need to be further enhanced. Policymakers should, therefore, shift to influencing the context to produce more positive effects on the innovation systems necessary for developing new health technologies and for training healthcare providers in the use of new medical technologies.

Conclusion:

The demand for syringes and cannulas in the MENA region is poised for significant expansion as the region remains committed to healthcare development and the application of technology. By focusing strategic investment and revising regulations and standards on regional cooperation, the region is not only responding to the emergent healthcare demand of populations today but also building a stronger and better healthcare system for the future. This willingness reflects positivism to increase health as well as illustrates that medical devices such as syringes and cannulas play an imperative part in enhancing such gains.

Contact Us:

UnivDatos Market Insights

Email - contact@univdatos.com

Contact Number - +1 9782263411

Website -www.univdatos.com

[amrutatbrc1]

Intravenous Infusion Pumps Market By Product Type, By Manufacturers, By End-User And Market Trend Analysis Forecast 2033

The intravenous infusion pumps global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Intravenous Infusion Pumps Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $5.71 billion in 2023 to $6.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to advances in medical technology, aging population, home healthcare services, hospital and healthcare facility expansion, regulatory standards.

The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $8.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing chronic disease burden, technological innovation, home infusion services, telehealth and remote monitoring. Major trends in the forecast period include smart infusion pumps, wireless and remote monitoring, home infusion therapy, precision medicine and personalized infusion.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rise in the prevalence of people with chronic pain, cancer, and diabetes is a significant driver of the demand for intravenous infusion pumps, as these pumps are commonly used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient's body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is expected to drive the growth of the intravenous infusion pumps market.

The intravenous infusion pumps market covered in this report is segmented –

1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products 2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users

Get an inside scoop of the intravenous infusion pumps market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp

Regional Insights - North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies - Major companies operating in the intravenous infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation

Table of Contents 1. Executive Summary 2. Intravenous Infusion Pumps Market Report Structure 3. Intravenous Infusion Pumps Market Trends And Strategies 4. Intravenous Infusion Pumps Market – Macro Economic Scenario 5. Intravenous Infusion Pumps Market Size And Growth ….. 27. Intravenous Infusion Pumps Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[healthcaremarketanalysis]

Prefilled Syringes Market worth $13.1 billion by 2030 driven by Rising Chronic Illness Rates | MarketsandMarkets™

The global Prefilled Syringes Market is expected to grow from USD 7.1 billion in 2024 to USD 13.1 billion by 2030, at a CAGR of 10.8%. Prefilled syringes are a convenient and precise medical device for delivering single doses of medication, reducing drug waste and extending product lifespan. They are increasingly adopted due to rising chronic illnesses, demand for effective drug delivery, and regulatory support for safer injection methods. Commonly used for biologics, vaccines, and other therapeutic products, these syringes enhance patient safety by minimizing errors and improving dosing accuracy. The market is expanding due to the prevalence of chronic diseases and the growing trend towards self-administration. However, challenges such as product recalls and competition from alternative drug delivery methods may impact growth. The market is driven by rising demand for biologics and biosimilars, with glass and single-chamber syringes expected to dominate. North America leads the market due to its advanced healthcare infrastructure and high demand for precise drug delivery solutions. Key players include BD, Gerresheimer AG, SCHOTT, and West Pharmaceutical Services, among others.

Download PDF Brochure:

Prefilled Syringes Market Dynamics

Drivers

· Rising target disease population

· Rapid growth in generic products

· Rising adoption of self-medication and digitalization

· Affordable cost with increased efficiency of prefilled syringes

· Technological advancements

Restraints

· Dearth of prefilled syringes with integrated safety features

Opportunities

· Growing healthcare infrastructure across emerging markets

· Surge of biologics and biosimilars in biopharma industry

· Increasing adoption of wearable drug delivery technologies

Challenges

· Availability of cheaper alternatives

· Challenges associated with manufacturing of prefilled syringes

Key Market Players

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (US), Baxter International Inc (US), Ompi (Italy), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan), Elcam Medical (Israel), YPSOMED (Switzerland), Oval Medical Technologies (UK), SHL Medical AG (Switzerland), Terumo (Japan).

Request Sample Pages

North America accounted for the largest market share of the global prefilled syringes industry, by region in the forecast period. The pre-filled syringe market is anticipated to be dominated by the North American region due to a number of factors, including an advanced healthcare infrastructure, a high prevalence of chronic diseases, and a focus on patient safety and technological innovation. Its dominant position in the market is also a result of the region’s well-established pharmaceutical industry and rising demand for practical and precise drug delivery solutions. Furthermore, continued R&D expenditures and favorable regulatory environments in North America contribute to the expansion and use of pre-filled syringes.

Recent Developments

· In October 2018, Becton, Dickinson and Company launched the BD Intevi 1mL two-step disposable autoinjector.

· In July 2020, Becton, Dickinson and Company entered into an partnership with Biomedical Advanced Research and Development Authority (BARDA) (US)

· In July 2018, Becton, Dickinson and Company acquired Teva Medical Inc. (US)

Content Source:

[researchrealmblog]

How Does Research and Development Boost Medical Injection-Molded Plastics Industry?

The medical injection-molded plastics industry has garnered $23,014.7 million revenue in 2021, and it is projected to rise at a rate of 5.7% from 2021 to 2030, to generate $37,899.5 million in 2030. It is ascribed to the rising consumption of plastic in various healthcare applications, including medical devices, mobility aids, and implant packaging.

Moreover, the surging research & development expenditure, and technological advancements in the healthcare sector propels the requirement for medical-grade injection-molded polymers.

Medical components capture the substantial industry revenue, of approx. 25% and it is further projected to follow the same trend from 2021 to 2030. It is attributed to the massive usage of high-grade plastics for medical equipment manufacturing, including catheters, syringes, containers, and medical bags.

Furthermore, the rising requirement for light and durable medical products, easy to sterilize is projected to propel the industry.

Additionally, the implants generate significant industry revenue, and their sales are projected to rise at a faster rate in the near future. It is ascribed to the rising elderly population, and the growing prevalence of dental implants, orthopedic disorders, endovascular disorders, and cardiovascular diseases.

In addition, the technological advancements in medical implants, led by extensive R&D to provide better results of medical procedures, cause industry propulsion.

Furthermore, mobility aids have experienced the highest CAGR, and it is projected to rise at the fastest rate in the future. It is ascribed to the worldwide rising elderly population, various technological advancements, and increasing healthcare expenses in developing countries.

Moreover, the rising usage of mobility aids, such as drinking aids, wheelchairs, and bath chairs, propels the market expansion.

Injection-molded plastics play a greater role in the transformation of the healthcare sector. These materials are used in the manufacturing of blood sample analysis cuvettes, pregnancy test devices, needle housing, and other medical components. It ensures their lightweight, easy sterilization, and higher affordability.

In addition, these polymers can be utilized in the production of disposable plastic syringes, and blood bags, by molding them. These plastics are used to create antibacterial contact interfaces that can kill bacteria and other pathogens, and reduce infection spread.

Moreover, these plastics can be customized to cater to the requirements of specific applications. They hold the potential to adapt to the smallest and most-delicate molds. Plastics are massively used in the production of surgical equipment, and products, including contemporary pacemakers, stents, catheters, and joint replacement systems.

North America holds the largest industry revenue, of over 40%, and it is projected to follow the same trend in the near future. It is ascribed to growing per capita income, surging healthcare costs, and a rising elderly population.

The U.S. captures a substantial share of the region-based industry, ascribed to highly advanced technology, growing demand for implantable devices, rising health awareness, healthcare policies, and government support.

APAC is projected to experience the fastest growth in the coming future, rising at a rate of over 6%. It is led by the growing application of injection-molded plastics in medical implants, components, and mobility aids.

In addition, the increasing consumer awareness of affordable medical products developed by molded products, rising concern on research and development of medical devices, and growing adoption of cutting-edge technologies in healthcare is projected to propel the industry growth.

Therefore, the medical injection molded plastics industry is projected to rise due to the increasing elderly population.

Source: P&S Intelligence

[poonamcmi]

Global Healthcare Consumables Market is Estimated to Witness High Growth Owing to Rising Use of Single-Use Products

Paragraph: The global healthcare consumables market consists of single-use or disposable medical supplies and devices that are used across various sections of the healthcare industry. Some key products in this market include syringes, cannulas, bandages, surgical gloves, drapes, masks and apparels. The growing preference for single-use consumables over reusable products is being driven by concerns of infection control and prevention of cross-contamination. The market provides convenient and hygienic products that can be safely discarded after single use.

The Global Healthcare Consumables Market is estimated to be valued at US$ 172.31 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the global healthcare consumables are Procter & Gamble, B. Braun SE, McKesson Medical-Surgical Inc, Medline Industries Inc., Owens and Minor, Smith And Nephew plc, 3M, Baxter, Fresenius Medical Care AG, Cardinal Health, Terumo Medical Corporation, Honeywell Interational Inc., Dynarex Corporation, Kemei, Unigloves, Argentum Medical, Alliqua Biomedical, AccelHeal, Globus Medical. These players are focusing on new product launches and partnerships to strengthen their presence across major markets.

The rising prevalence of chronic diseases and growing geriatric population susceptible to various healthcare conditions offer considerable growth opportunities for players in this Global Healthcare Consumables Market Demand With rising healthcare expenditure globally and improving access to healthcare, demand for consumables is expected to surge significantly over the coming years especially in developing regions.

The market is witnessing increased global expansion with players focusing on emerging countries using strategies like facility expansion, joint ventures and establishing manufacturing plants in such regions to cater to the rising local demand. Regions like Asia Pacific and Latin America offer high growth potential owing to developing healthcare infrastructure and rising medical tourism. Market drivers:

The key driver for the Healthcare Consumables Market Size And Trends  is the ability of single-use consumables to reduce healthcare associated infections and prevent cross-contamination. Other factors like growing healthcare reforms advocating use of disposables, rising surgical procedures, technological advancements and increasing focus on patient safety and hygiene also contribute to the rising demand in this market. With growing med-tech investment and new product development, the market is expected to surge at a steady pace during the forecast period.

PEST Analysis Political: Healthcare consumables market growth is impacted by various regulations related to medical devices and healthcare standards set by the government and healthcare authorities.

Economic: Changes in consumer spending on healthcare and rising disposable incomes impacts demand for healthcare consumables.

Social: Growing geriatric population, increasing prevalence of chronic diseases, and adoption of preventive healthcare drives demand for consumables.

Technological: Advances in medical technology, materials used for manufacturing consumables, and focus on developing eco-friendly products helps grow the market. New technologies also help lower costs and improve quality.

North America region holds the largest market share currently due to developed healthcare infrastructure, availability of reimbursement policies, and presence of key players in the region. The Asia Pacific region is forecasted to grow at the fastest rate over the forecast period due to growing healthcare sector, rising medical tourism, increasing per capita expenditure on healthcare, and growing demand from developing countries like China and India.

The Europe region is also growing at a significant rate supported by improving access to healthcare, government support for research & development, and presence of major established players. The Latin America and Middle East & Africa regions also offer lucrative opportunities for market growth in the coming years. Get More Insights On, Global Healthcare Consumables Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[deshpandeisha]

Exploring the Insulin Delivery Market: Innovations and Impact

The global insulin delivery market size reached USD 17.80 billion in 2021 and is expected to register a revenue CAGR of 9.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing number of diabetes patients across the globe, including increase in obese and elderly population, changes in lifestyles, and adequate/established healthcare services are driving market revenue growth. 

Innovations Driving Change:

Smart Insulin Pens: These high-tech pens track doses, offer reminders, and sync data with apps for better management.

Continuous Glucose Monitors (CGMs): While not traditional delivery methods, CGMs are game-changers, providing real-time glucose levels and reducing the need for frequent injections.

Insulin Pumps: These devices automate insulin delivery, mimicking the pancreas's natural function, offering precise control over glucose levels.

Market Dynamics: The market is buzzing with innovation and competition, pushing companies to create more reliable, affordable, and user-friendly solutions. From traditional syringes to cutting-edge wearable tech, options are expanding.

Impact on Diabetes Management: Improved delivery methods mean better adherence to treatment plans, fewer complications, and enhanced quality of life for those managing diabetes.

Challenges Ahead: Despite advancements, challenges like cost, accessibility, and regulatory hurdles persist, limiting universal access to these innovations.

The leading market contenders listed in the report are: Sanofi Diabetes, Nova Nordisk, Omnipod Insulin Management, Eli Lilly and Company, Gerresheimer, Johnson and Johnson, Becton Dickinson, Medtronic PLC, Hoffmann-La Roche Ltd., Braun

The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs. To Visit Full Report & Table of Contents Insulin Delivery Market: https://www.emergenresearch.com/industry-report/insulin-delivery-market

Market Overview: The report bifurcates the Insulin Delivery market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment. Segments Covered in this report are:

Diabetes Type Outlook (Revenue, USD Billion; 2019-2030)

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Prediabetes

Device Type Outlook (Revenue, USD Billion; 2019-2030)

Insulin Syringe

Insulin Pens

Disposable

Reusable

Insulin Jet Injectors

Insulin Pumps

Tethered

Patch

Insulin Needles

Standard Needles

Safety Needles

Insulin Inhalers

External Insulin

Implantable Insulin

Others

Route of Administration Outlook (Revenue, USD Billion; 2019-2030)

Oral/Buccal

Nasal

Subcutaneous Route

Transdermal Route

Others

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/1432

Regional Analysis Covers: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key reasons to buy the Global Insulin Delivery Market report:

The latest report comprehensively studies the global Insulin Delivery market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1432

[focusedmarketinsights]

The global syringes and needles market has experienced a surge in demand, driven primarily by factors such as a rising geriatric population, heightened consumer awareness, the prevalence of chronic diseases, and the burgeoning use of syringes and needles for diabetes management. Further propelling the market's growth are technological advancements, the proliferation of new product launches, robust healthcare infrastructure, intensive R&D initiatives, the presence of leading vendors, and supportive governmental policies.

In a more detailed breakdown, as of 2023, syringes command a market share of 66.89%, with predictions indicating an upward trajectory at a CAGR of 8.16%. This growth can be attributed to the escalating demand for disposable syringes fueled by aggressive immunization and vaccination drives. Additionally, adults constitute the largest patient segment, capturing a 69.25% market share in 2023 and projected to achieve 70.16% by 2029. This is largely due to the proliferation of chronic diseases among adults and the spike in diabetic cases.